Center for Bioprocessing

Sino Biological is a global biotechnology company and contract research organization (CRO) specializing in recombinant protein production and antibody development. The company provides a vast catalog of research reagents, including over 6,500 proteins and 13,000 antibodies, alongside custom manufacturing services for the pharmaceutical and diagnostic industries. In 2023, Sino Biological expanded its global footprint by opening the Center for Bioprocessing (C4B) in Houston, Texas, which serves as its first U.S.-based manufacturing facility. C4B focuses on high-quality, mammalian cell-based production of proteins and antibodies to support localized drug discovery and preclinical research. The company is publicly traded on the Shenzhen Stock Exchange and serves thousands of clients across more than 90 countries.